Rare diseases
Investigational molecules
Locations
A study testing duvakitug for patients with moderately to severely active ulcerative colitis
GermanyA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
GermanyStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
GermanyLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
GermanyStudy of tasimelteon compared to placebo for treating insomnia in children
GermanyStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
GermanyStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
